The yeast two-hybrid system was used to screen a library of random peptides fused to a transcrlptional activation domain In order to identify peptides capable of binding to the retinoblastoma protein (Rb). Seven peptides were identified, all of which contain the Leu-X-Cys-X-Glu motif found in Rb-bindlng proteins, although their activity in the yeast assay varied over a 40-fold range. Mutagenesis of the DNA encoding two of these peptides followed by screening in the twohybrid system allowed the delineation of residues apart from the invariant Leu, Cys and Glu that affect binding to Rb. Binding affinities of a peptide and one of its variants to Rb, determined by surface plasmon resonance, correlated with results from the two-hybrid assay. This method offers several advantageous features compared to existing technology for screening peptide libraries: In vivo detection of protefn-peptfde Interactions, high sensitivity, the capacity for rapid genetic screening to identify stronger and weaker binding peptide variants, and the use of a simple assay (transcrlptional activity) as a means to assess binding affinity.
INTRODUCTION
Combinatorial libraries of macromolecules are finding increasing use as a means to identify ligands for biologically important targets. In particular, diverse approaches have been developed for the generation of large arrays of random peptides. These include libraries synthesized in vivo and displayed on the surface of a filamentous phage (1-3) or at the carboxy terminus of the lac repressor protein (4), and others synthesized chemically and coupled to resin beads (5). Biologically-derived peptide libraries are screened by sequential rounds of affinity enrichment ('panning')-Phage display libraries allow very complex mixtures of peptides to be screened; peptides with the relevant binding activity initially present at low abundance are amplified in subsequent rounds of infection. The primary structure of the specific peptides are then identified by DNA sequence analysis of the phage DNA. By contrast, peptides identified from chemicallyderived libraries are generally characterized by Edman degradation (5) or by the analysis of molecular tags that had been attached to the beads for recording steps of the synthesis (6,7). These libraries have the advantage of allowing the incorporation of unnatural amino acids into the peptides. Recently, an in vitro polysome display system has been designed to select peptide ligands from' 10' 2 random peptides (8). All of these methods detect protein-peptide binding under in vitro conditions, and require further biochemical experiments to determine affinity values for peptides identified in the random screen. Additionally, they have limited capacity for rapid discrimination of tighter or weaker binding variants. We describe here the use of a peptide library in the yeast two-hybrid system (9,10) which has unique features relative to existing technology.
The two-hybrid system relies on the modular nature of many eukaryotic site-specific transcriptional activators to generate a transcriptional signal from the interaction of a protein fused to a DN A-binding domain with another protein fused to a transcription activation domain. Unlike other methods, the two-hybrid system detects protein-protein interactions occurring in vivo. This leads to a high degree of sensitivity [see for example (11,12)], presumably due to an amplification effect in which a transient interaction can lead to multiple rounds of transcription and translation and the production of stable reporter proteins such as E.coli (J-galactosidase. Furthermore, as a microbially-based assay, this system allows both the direct selection of only those yeast transformants that express a desired protein-protein interaction as well as the use of simple genetic strategies to identify small protein domains or single amino acid residues critical for such an interaction (11,12).
MATERIALS AND METHODS

DNA constructions and mutagenesis
Plasmids encoding the activation domain hybrids with T antigen peptides were generated by PCR amplification of the indicated T antigen sequences. The LTP hybrid was generated in pGAD.GH (13) and the LTP-Leu hybrid in pGAD424 (14) . The peptide library was generated using the oligonucleotide 5'-GAAC-TAGTGGATTCCC(NNK)i 6 TAGGAATTCGGCCGC-3' (N is an equal mixture of all four deoxynucleotides; K is an equal mixture of G and T) to encode 16 random codons flanked by DNA To whom correspondence should be addressed sequences containing BamW and EcoRl restriction sites. PCR amplification was performed using 26 pmol oligonucleotide and 6 nmol of the primers 5'-GAACTAGTGGATTCCC-3' and 5'-GCGGCCGAATTCCrA-3'. After digestion with BamHl and EcoRi, fragments were ligated into pGAD.GH and electroporated into the Kcoli strain DH5a to generate a library with -10 7 inserts. Fifty plasmids were randomly chosen and sequenced. All contained inserts; -15% of the inserts encoded peptides of <16 residues, due to the presence of termination codons generally resulting from a missing nucleotide in the oligonucleotide synthesis.
To generate hybrids of a peptide with the Gal4 DNA-binding domain, the multiple cloning site in the vector pGBT9 (14) was modified to match to that of the pGAD.GH. The EcoRl of pGBT9 was changed to a Spel site using the adaptor 5'-AATACTAGT-3', and then the SpelSaR fragment of the plasmid pBS SK ± (Stratagene Co., San Diego, USA) containing the multiple cloning site was inserted into the SpeVSaK sites to generate pGBT9BS. DNA sequences encoding peptides PI, Pl-al, P7, and P7-14 in the vector pGAD.GH were isolated as BdmHl-EcoRl fragments and ligated into pGBT9BS.
To create a fusion of glutathione S-transferase to Rb residues 301-928, the EcoRi site of pGEX-3X (Pharmacia, Uppsala, Sweden) was changed to a Sail site using the adaptor 5'-AATTGTCGAC-3', and the Bamm-Sall fragment of pASRb2 (15) was inserted into this vector.
Mutations were generated by using PCR under suboptimal conditions as described (16) .
Yeast methods
The yeast reporter strain Y153 (14) was transformed and screened for His" 1 " lacZ + colonies, plasmids were recovered and analyzed, and p-galactosidase activity was determined as described (17) . Values for liquid pVgalactosidase assays represent the mean of at least four assays, and the standard errors were generally 10-20% of the mean.
Surface plasmon resonance analysis
The GST-Rb fusion was purified as described (18) . Peptides were purchased from Quality Controlled Biochemicals, Inc. (Hopkinton, MA). Binding kinetics were determined by surface plasmon resonance (BIAcore, Pharmacia Biosensor). Purified GST-Rb was diluted to 15 pg/ml in sodium acetate buffer (10 mM, pH 4.5) and was coupled to the dextran-modified gold surface of a CM5 sensor chip (Pharmacia Biosensor) using-amine coupling chemistry [A r -hydroxysuccinimidaW-ethyl-A''-(3-dimethylaminopropyl)-carbodiimide] as described in the system manual. Peptides were dissolved in 10 mM NaOH and the pH was adjusted to 7.4 prior to being diluted to the desired concentrations in HBS buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 3.4 mM EDTA, 0.005% Surfactant P-20) containing 100 ng/ml BSA. Serial dilutions of each peptide (1-10 pJvi of PI and 5-50 (iM of Pl-al) were injected over the GST-Rb coupled surface at 8 (il/min. Sensorgrams were recorded and normalized to a baseline of 0 resonance units (RU). Data were fitted to a single site binding model of A + B = AB by non-linear least squares curve fitting using BIAevaluation 2.0 software (Pharmacia Biosensor). The equation R t = R o x expHtoffX (t-t 0 )] was used for the dissociation phase, where R t was the amount bound in RU at time /, and t 0 was the beginning of the dissociation phase. In one experiment, the dissociation rate constant (Jkoff) of PI binding was (5.03 ± 0.35) xl0-3 s-',and of Pl-al binding was(1.13±0.05)xl0-2 s-1 ). The equation R t = #«, x {1 -expf-Jfcs x (t-t o )]} was used for the association phase, where k s = k on xC + /toff and the association rate constant ^ was calculated by the linear curve fitting of a plot of ^ versus C. R^ was the amount bound in RU at equilibrium, / 0 was the time that injection started, and C was the concentration of peptide injected. In one experiment, for P1, k^ = (3.77 ± 0.20) x 10^ M-1 s" 1 (correlation coefficient, R -0.983) and for Pl-al, *on = (1.48±0.12)x lC^M" 1 s-' (# = 0.974). For this experiment, the equilibrium constants KD (calculated from the ratio koff/kon) are 13.3(iMforPl and 76.4 ^M for PI -a \.Kov/as also calculated by the linear curve fitting of a plot of Req versus Req/C using the equation Req/C = 1/^D X ^max-l/^D x #eq. where flmax is the maximum binding in RU when the surface is saturated and /?eq was calculated as above.
RESULTS AND DISCUSSION
Identification of Rb-binding peptides
To test the feasibility of the two-hybrid system to detect protein-peptide interactions, we chose to analyze the binding of small peptides to the human retinoblastoma (Rb) protein. Rb binds to viral oncogene products such as SV40 large T antigen, adenovirus EIA and human papilloma virus E7 and to cellular proteins such as D-type cyclins (19) . Rb-binding in these cases is mediated by the amino acid motif Leu-X-Cys-X-Glu (20) (21) (22) (23) . We generated Gal4 activation domain hybrids that contain peptides from SV40 large T antigen: the LTP (for Large 1 antigen Eeptide) hybrid contains residues 103-115, which begins with the Leu of the conserved motif, and the LTP-Leu hybrid contains residues 104-115 (Table 1 ). The plasmid pASRb2 (15) encodes residues 301-918 of Rb fused to me Gal4 DNA-binding domain (BD-Rb). When the hybrid proteins LTP and BD-Rb were co-expressed in a yeast reporter strain, binding of the T antigen peptide to Rb was observed as substantial (3-galactosidase activity (Table 1) . By contrast, the LTP-Leu construct resulted in only background transcriptional activity (Table 1 ), indicating that protein-peptide interactions can be specifically detected in two-hybrid assays. •Peptide sequences are aligned by the conserved residues (indicated in bold); LTP is derived from SV40 large T antigen.
•"Activity was determined as in (17) . We constructed a library of 16-residue long peptides fused to the Gal4 activation domain and screened it to identify Rb-binding peptides (Fig. 1) . The library was generated by cloning a pool of random oligonucleotides into the Gal4 activation domain vector pGAD.GH (13); the total complexity was 10 7
. Statistically, the library should encompass at least all possible pentamer peptides. We cotransformed this library with pASRb2, encoding the Gal4 DNA-binding domain fusion to Rb, into a yeast reporter strain; selection was for the ability of transfonnants to grow in the absence of histidine by virtue of the expression of the Gal4-dependent gene GAL1-H1S3. His + colonies were also screened by a filter lift assay for expression of another Gal4-dependent gene GALl-lacZ. Of three million transformants, seven peptides that bind to Rb were identified (Table 1) .
All seven peptides contain the conserved Leu-X-Cys-X-Glu motif. However, transcriptional activity in the two-hybrid assay varied more than 40-fold, indicating that residues other than the three invariant ones play a role in determining this activity. Notably, the five peptides producing the most pVgalactosidase activity have a high net negative charge (average -2.6) and contain no Arg or Lys residues. In contrast, P6 has an overall charge of-1 and contains a single Lys residue, and P7 is overall neutral and contains three Arg residues (Table 1) . Additionally, the peptides producing the most activity tend to be hydrophobic in nature. Thus PI, with a net charge of-4 and six hydrophobic residues (apart from the invariant Leu and Cys), produced more than 7-fold greater (J-galactosidase activity than did P4, with a net charge of -5 but only a single hydrophobic residue outside the invariant motif. The similar activity of PI and the large T antigen peptide may be due to the presence of a negatively charged residue immediately C-terminal to the conserved motif. Figge et al. (22) analyzed the sequences of the Rb-binding domain from 21 proteins and derived a consensus that includes a net negative charge flanking the conserved motif, a bias against Lys and Arg residues, and an overall hydrophobic nature. However, their consensus includes such features as an Asp, Asn or Thr immediately N-terminal to the conserved Leu, as well as a Glu or Asp one to three residues N-terminal to the conserved Leu; these features are not found in the PI peptide.
Affinity analysis
To analyze the role of residues other than the conserved motif, we took advantage of the ability in the two-hybrid system to readily detect changes in transcriptional activity as colonies that are darker or lighter blue in the Xgal filter assay. We randomly mutagenized the peptide PI, displaying greatest activity, and P7, with least activity, by amplifying their corresponding oligonucleotides using suboptimal PCR (16) and cloning of the PCR products into the activation domain vector. We obtained six peptides derived from P1 that produced less pVgalactosidase activity than P1, and two that produced similar activity (Table 2 ). All six with decreased activity have a mutation that leads to a +1 change in charge, either by loss of an Asp or Glu or gain of an Arg. The two peptides with similar activity to PI have no net change in charge. For P7, the two mutants with increased activity have additional negative charge; change of an Arg residue to a neutral residue (Gly) doubled the activity whereas change of this residue to an acidic residue (Glu) led to more than a 3-fold increase (Table 2) . Pl-h ---R ______ 27
Pl_l __ _ R __. ______ 22
To compare the two-hybrid results with biochemical affinity determinations, we synthesized the peptides PI, Pl-al, P7 and P7-14 (Table 2 ) and purified Rb from E.coli as a glutathione S-transferase fusion protein. Association and dissociation kinetics were measured using surface plasmon resonance technology (24) with a BIAcore system (Pharmacia Biosensor). PI bound to Rb with an apparent K& of 13-23 |iM, and Pl-al with an apparent K D of 61-76 uM. The binding of neither P7 nor P7-14 could be detected by this assay. These results correlate well with our initial identification of PI and P7 as peptides producing the greatest and least pVgalactosidase activities, respectively. Additionally, PI produced 4.2-fold more activity in the two-hybrid assay than the Pl-al mutant identified as having lower activity; this result compares with the ~4-fold effect in the BIAcore binding assay. These binding data suggest that the two-hybrid assay can detect affinities well above ~70 fiM, which compares with K^ values as high as 100-500 (iM that can be detected with phage and LacI display systems (25) .
Use of peptides in DNA-binding domain hybrids
We switched the orientation of the Rb domain and selected peptides such that the Rb domain was fused to the Gal4 activation domain (AD-Rb) and the peptide to the Gal4 DNA-binding domain. For the combinations that included P7 and its mutant P7-14, the two-hybrid transcriptional signals (Table 3) were similar to those with the original orientation ( Table 2 ). These results indicate that small peptides could serve as potential targets in a two-hybrid approach to identify proteins that bind to a peptide of interest. For the PI peptide, the DNA-binding domain alone produced substantial transcriptional activity, possibly due to the high negative charge of the peptide. We obtained much greater p^-galactosidase activity when AD-Rb was co-expressed (Table  3 ), indicating that binding between Rb and the peptide occurred. However, the two PI mutants produced reduced transcription both in the absence and presence of AD-Rb compared to the wild type PI sequence (Table 3) . Therefore, it is not possible to use the two-hybrid assay with peptides of this type to assess their binding affinities to some protein, as mutations can affect intrinsic transactivation capacity as well as protein-peptide interaction. The combinatorial peptide library we describe here allows the identification of specific peptides in a single round of screening. Furthermore, the peptides bind to their target proteins within the cellular milieu, an advantageous feature for peptides that are designed for in vivo uses. Biochemical analysis of proteinpeptide binding correlates well with the two-hybrid results, indicating that rapid assessments of affinity can be performed using the yeast assay. These features suggest that the two-hybrid system may have relevance for drug discovery schemes based on the identification of peptides with affinity for selected proteins. Initially, peptides identified in the two-hybrid assay may have low binding affinity. However, the sequence of these peptides may suggest a consensus for binding. In a second stage, mutagenesis of individual peptides and rapid rescreening in yeast can be performed. This stage can determine which residues are critical for binding and which residues can be mutated without loss of binding. It may also identify new peptides with increased affinity. Ultimately, the peptides identified as having the highest affinity might form the basis for the synthesis of mimetics to be used as therapeutic agents. It should also be feasible to design simple genetic assays to identify peptide variants capable of binding to one target protein but not to another. For example, it might be possible to identify peptides that discriminate between wild type and mutant versions of a protein. The two-hybrid assay might also be capable of identifying peptides that can inhibit specific protein-protein interactions; such peptides could be synthesized within cells to examine the phenotypic consequences.
While the peptides used in these applications have a free carboxy terminus, it is likely that the peptide moiety can also function when present at the amino terminus of the hybrid protein.
In either of these cases, one end of the peptide would be unconstrained by other portions of the polypeptide. However, it should also be feasible to construct the peptide library such that the insertion is flanked at both ends by domains of the polypeptide such that the peptide is embedded in a rather rigid structure.
In contrast to some phage display libraries, there is no limit to the number of residues that can comprise the peptide in the two-hybrid assay. Finally, peptides found in screening an activation domain library can themselves be used as targets in a two-hybrid search to identify cellular proteins capable of binding these peptides.
